多发性骨髓瘤的单细胞分析:见解、问题与前景
单细胞平台在多发性骨髓瘤(MM)研究中已成为常规,可捕捉批量评估遗漏的细胞异质性与细胞间相互作用。本文综述单细胞分析的类型与实验设计考量,并讨论其在骨髓瘤克隆演化、转录重编程、耐药及微环境(前驱与进展期)方面的发现与待解决问题。
要点
- 单细胞平台可揭示MM中批量评估遗漏的细胞亚群异质性与细胞间相互作用。
- 单细胞分析已为骨髓瘤克隆演化、转录重编程和耐药提供重要见解。
- 单细胞研究在前驱与进展期MM微环境方面已有发现,但仍有大量工作待完成。
核心结论
- 单细胞研究已对MM发病机制提供重要见解,但仍有大量工作待完成。
研究设计与样本
- 综述:聚焦单细胞分析的类型及设计单细胞分析实验的考量,并汇总MM克隆演化、转录重编程、耐药及微环境方面的单细胞研究见解。
主要发现
- MM中大量细胞异质性使单细胞平台尤其有吸引力,因为批量评估可能遗漏细胞亚群和细胞间相互作用的有价值信息。
- 单细胞平台成本下降、可及性提高,加上同一细胞多组学数据获取的突破和数据分析计算程序的创新,使单细胞研究得以对MM发病机制提供重要见解。
局限性
- 原文指出单细胞研究仍有许多工作要做。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In a short time, single-cell platforms have become the norm in many fields of research, including multiple myeloma (MM). In fact, the large amount of cellular heterogeneity in MM makes single-cell platforms particularly attractive because bulk assessments can miss valuable information about cellular subpopulations and cell-to-cell interactions. The decreasing cost and increasing accessibility of single-cell platform, combined with breakthroughs in obtaining multiomics data for the same cell and innovative computational programs for analyzing data, have allowed single-cell studies to make important insights into MM pathogenesis; yet, there is still much to be done. In this review, we will first focus on the types of single-cell profiling and the considerations for designing a single-cell profiling experiment. Then, we will discuss what have learned from single-cell profiling about myeloma clonal evolution, transcriptional reprogramming, and drug resistance, and about the MM microenvironment during precursor and advanced disease.
引用
- Samur MK, Szalat R, Munshi NC, et al. Single-cell profiling in multiple myeloma: insights, problems, and promises. Blood. 2023. PMID: 37196627. doi:10.1182/blood.2022017145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。